OUTPATIENT LIVER-BIOPSY - HOW SAFE IS IT

被引:125
作者
GARCIATSAO, G [1 ]
BOYER, JL [1 ]
机构
[1] YALE UNIV, SCH MED, DEPT MED, 333 CEDAR ST, 1080 LMP, NEW HAVEN, CT 06510 USA
关键词
BIOPSY; NEEDLE; AMBULATORY CARE; LIVER DISEASES; BLEEDING TIME; SAFETY;
D O I
10.7326/0003-4819-118-2-199301150-00013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Percutaneous liver biopsy is being done more frequently as a result of major changes in the therapy of liver diseases. The ease and safety of outpatient. ''blind'' liver biopsy has been well established. Complication rates have ranged from 0.9% to 3.7%; most complications have become manifest within the first 3 hours after biopsy, and none has resulted in death. Nevertheless, differing guidelines may affect relative degrees of safety in different Centers. A review of reported series suggests that the Menghini technique may be the preferred first choice. with the Tru-Cut technique reserved for patients in whom an adequate sample cannot be obtained. The requirement of a normal bleeding time appears to decrease the incidence of hemorrhagic complications. The decision to use outpatient biopsy must be based on a careful assessment of the risks and benefits for each individual patient.
引用
收藏
页码:150 / 152
页数:3
相关论文
共 22 条